Results 201 to 210 of about 580,692 (357)

Financial Justifications for the Software-as-a-Service Business Model Trend Based on Financial Differences between Companies in the Software-as-a-Service and Pharmaceutical Industry

, 2021
Johannes Lindvall, Daniel Olsson
openalex   +1 more source

Using Long‐Chain Polymechanophores to Explore the Differences in Mechanoactivation During Nozzle Flow and Ultrasonication

Advanced Functional Materials, EarlyView.
Flow through a nozzle is a common component of most fluid‐based polymer processing techniques such as spray drying, inkjet printing, extrusion. An ultrahigh molecular weight multi‐mechanophore system is used to probe the differences in the distribution of mechanical activation observed between nozzle flow and ultrasonication; the gold standard ...
Niamh Willis‐Fox, Maggie Horst, Etienne Rognin, Yan Xia, Ronan Daly   +4 more
wiley   +1 more source

Recent Advances in Mitochondrial Pyruvate Carrier Inhibitors

Pharmaceutical Fronts
Yilei Huang, Han Zhang, Xinyan Peng, Qingwei Zhang   +3 more
doaj   +1 more source

Why the Pharmaceutical Industry Needs Implementation Science for Sustainable Innovation. [PDF]

Pharmaceut Med
Messina AJ.
europepmc   +1 more source

Spin‐Dependent Generation of Surface‐Bound Radicals Toward Selective and Long‐Lasting Water Purification

Advanced Functional Materials, EarlyView.
This study develops a novel atomic engineering strategy to fine‐tune the spin state of α‐Fe2O3 catalysts toward a medium‐spin state, thereby modulating peroxymonosulfate activation and selectively yielding surface‐bound radicals. Compared with free radicals, surface‐bound radicals exhibit moderated oxidation potential, extended lifespan, surface ...
Shuyu Wang, Zhonglin Chen, Jimin Shen, Pengwei Yan, Jing Kang, Binyuan Wang, Shengxin Zhao, Xiaoguang Duan   +7 more
wiley   +1 more source

A new selective culture medium for isolation of <i>Burkholderia cepacia</i> complex in pharmaceutical industry. [PDF]

Front Microbiol
Yu M, Wang S, Zhong Y, Yuan L, An L, Feng D, Liu Z, Ma S.   +7 more
europepmc   +1 more source

Poly(lactic‐co‐glycolic acid) Nanoparticles for IL‐12 Self‐Amplifying RNA Delivery in Glioblastoma Models

Advanced Functional Materials, EarlyView.
xxxx. ABSTRACT Glioblastoma (GBM) remains one of the most lethal brain cancers, with median survival rarely exceeding 15 months after diagnosis. Interleukin‐12 (IL‐12) is a potent immunostimulatory cytokine capable of reshaping the tumor microenvironment (TME), yet its clinical translation is hindered by systemic toxicity and short half‐life. RNA‐based
Fatima Hameedat, Johan Sebastian Lopez‐Parra, Willem M. H. Hoogaars, Emma Dijkstra, Cynthia Huang, Irafasha C. Casmil, Anna K. Blakney, Peter Olinga, Barbara Rothen‐Rutishauser, Hélder A. Santos, Alke Petri‐Fink, Flávia Sousa   +11 more
wiley   +1 more source

An Improved Synthesis Process of Ricolinostat: The First Orally Selective HDAC6 Inhibitor

Pharmaceutical Fronts
Mengfei Wang, Niubing Sun, Qiushi Chen, Qingwei Zhang   +3 more
doaj   +1 more source

Empowering the pharmaceutical industry by revolutionizing education. [PDF]

Daru
Hajimiri SH, Soleymani F.
europepmc   +1 more source

THE EFFECTS OF ALLIANCE PORTFOLIO DIVERSITY ON INNOVATION PERFORMANCE: A STUDY OF PARTNER AND ALLIANCE CHARACTERISTICS IN THE BIO-PHARMACEUTICAL INDUSTRY

, 2016
Klaus Marhold, Marco Jinhwan Kim, Jina Kang   +2 more
openalex   +1 more source